SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-10-186934
Filing Date
2010-08-12
Accepted
2010-08-12 11:56:05
Documents
2
Period of Report
2010-09-09
Effectiveness Date
2010-08-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 199122
2 GRAPHIC g44317g37n39.jpg GRAPHIC 17244
  Complete submission text file 0001193125-10-186934.txt   224477
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 101010169
SIC: 2834 Pharmaceutical Preparations